Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, has appointed Stuart Grant as executive vice president (EVP) and chief financial officer (CFO). Grant comes to Patheon following an accomplished career with increasing levels of responsibility in finance for several successful, global public companies.
Grant is joining Patheon after serving as senior vice president (SVP) and CFO of BioCryst Pharmaceuticals, where he was a key player in the creation and execution of a company-wide strategy that stabilised, funded and enabled future operations of the company. His responsibilities included the finance, information technology, supply chain operations, manufacturing and communications functions.
Prior to joining BioCryst, Grant was group CFO for Serono where he worked for 12 years, three years in his last position, until the company was acquired. Grant also spent 15 years in finance at Digital Equipment Company and several years working as a tax consultant and senior auditor for Price Waterhouse in Glasgow, Scotland.
Grant holds a Bachelor of Accountancy from the University of Glasgow, Glasgow, Scotland and is a chartered accountant with the Institute of Chartered Accountants of Scotland (ICAS).
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more